AR and breast cancer: Our results demonstrated that a RET protocol could significantly reduce DHEA-S and cortisol/DHEA-S levels, regardless of HT, with a possible protective role on cancer relapse, as androgen receptors modulate BC cell growth both with a genomic and nongenomic pathway [74].